BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11757182)

  • 1. Centroblastic-centrocytic non-Hodgkin's lymphoma stage I-III: patterns of failure following radiotherapy.
    Frank C; Zierhut D; Schulz-Ertner D; Wannenmacher M
    Strahlenther Onkol; 2001 Nov; 177(11):597-603. PubMed ID: 11757182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-frühe Stadien.
    Stuschke M; Hoederath A; Sack H; Pötter R; Müller RP; Schulz U; Karstens J; Makoski HB
    Cancer; 1997 Dec; 80(12):2273-84. PubMed ID: 9404705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome and prognostic factors in early-stage nodal low-grade non-hodgkin's lymphomas treated with radiation therapy.
    Eich HT; Heimann M; Stützer H; Kriz J; Reiser M; Müller RP
    Strahlenther Onkol; 2009 May; 185(5):288-95. PubMed ID: 19440667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
    Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiotherapy of follicle center lymphoma. Results of a German multicenter and prospective study. Members of the Study Group "NHL-early stages"].
    Sack H; Hoederath A; Stuschke M; Bohndorf W; Makoski HB; Müller RP; Pötter R
    Strahlenther Onkol; 1998 Apr; 174(4):178-85; discussion 186. PubMed ID: 9581177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
    Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
    Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
    Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation.
    Guckenberger M; Alexandrow N; Flentje M
    Radiat Oncol; 2012 Jun; 7():103. PubMed ID: 22726938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone.
    Dühmke E; Diehl V; Loeffler M; Mueller RP; Ruehl U; Willich N; Georgii A; Roth S; Matthaei D; Sehlen S; Brosteanu O; Hasenclever D; Wilkowski R; Becker K
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):305-10. PubMed ID: 8892452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study.
    Richaud PM; Soubeyran P; Eghbali H; Chacon B; Marit G; Broustet A; Hoerni B
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):387-90. PubMed ID: 9457825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
    Kamath SS; Marcus RB; Lynch JW; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):563-8. PubMed ID: 10348285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.
    Krol AD; Berenschot HW; Doekharan D; Henzen-Logmans S; van der Holt B; van 't Veer MB
    Radiother Oncol; 2001 Mar; 58(3):251-5. PubMed ID: 11230885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone.
    Dühmke E; Franklin J; Pfreundschuh M; Sehlen S; Willich N; Rühl U; Müller RP; Lukas P; Atzinger A; Paulus U; Lathan B; Rüffer U; Sieber M; Wolf J; Engert A; Georgii A; Staar S; Herrmann R; Beykirch M; Kirchner H; Emminger A; Greil R; Fritsch E; Koch P; Drochtert A; Brosteanu O; Hasenclever D; Loeffler M; Diehl V
    J Clin Oncol; 2001 Jun; 19(11):2905-14. PubMed ID: 11387364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
    Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control.
    Mendenhall NP; Rodrigue LL; Moore-Higgs GJ; Marcus RB; Million RR
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):551-61. PubMed ID: 10348284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.
    Reinartz G; Molavi Tabrizi C; Liersch R; Ullerich H; Hering D; Willborn K; Schultze J; Micke O; Ruebe C; Fischbach W; Bentz M; Daum S; Pott C; Tiemann M; Moeller P; Neubauer A; Wilhelm M; Lenz G; Berdel WE; Willich N; Eich HT
    Oncologist; 2020 May; 25(5):e816-e832. PubMed ID: 32219909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma.
    Pendlebury S; el Awadi M; Ashley S; Brada M; Horwich A
    Radiother Oncol; 1995 Sep; 36(3):167-71. PubMed ID: 8532901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
    Mac Manus MP; Hoppe RT
    J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.